skip links

Media Inquiries

Beth Calitri

Corporate Communications, Media Relations

978.417.2031

[email protected]
Sort by Year
January 3, 2012

Ironwood Pharmaceuticals to Present at J.P. Morgan Healthcare Conference

November 7, 2011

Ironwood Pharmaceuticals Provides Third Quarter 2011 Investor Update

November 2, 2011

Ironwood Pharmaceuticals to Present at Credit Suisse 2011 Healthcare Conference

October 31, 2011

Ironwood Pharmaceuticals to Host Third Quarter 2011 Investor Update Call

October 27, 2011

Ironwood and Forest to Present Linaclotide Results from Phase 2B and Phase 3 Trials in Patients with Irritable Bowel Syndrome with Constipation or Chronic Constipation

October 24, 2011

Ironwood and Forest Announce Linaclotide New Drug Application for the Treatment of Irritable Bowel Syndrome with Constipation and Chronic Constipation Accepted for FDA Review

September 29, 2011

Ironwood Announces Linaclotide European Regulatory Submission for the Treatment of Irritable Bowel Syndrome with Constipation

September 21, 2011

Ironwood Pharmaceuticals to Present at Jefferies 2011 Global Healthcare Conference

September 6, 2011

Ironwood Pharmaceuticals to Present at Morgan Stanley Global Healthcare Conference

August 11, 2011

Ironwood Pharmaceuticals Provides Second Quarter 2011 Investor Update

August 10, 2011

Ironwood Pharmaceuticals to Present at Wedbush Securities 2011 Life Sciences Management Access Conference

August 9, 2011

Ironwood and Forest Announce Submission of New Drug Application for Linaclotide for the Treatment of Irritable Bowel Syndrome With Constipation and Chronic Constipation

August 8, 2011

Ironwood Pharmaceuticals to Host Second Quarter 2011 Investor Update Call

July 27, 2011

Ironwood Pharmaceuticals and Depomed Announce Collaboration, Research and License Agreement

May 31, 2011

Ironwood Pharmaceuticals Announces Upcoming Presentations at Jefferies Global Healthcare Conference and Goldman Sachs Annual Global Healthcare Conference